Tag: Pharmaceutical

Japanese stocks retreat as firmer yen weighs on exporters

TOKYO, Nov 19 (Reuters) – Japanese shares slipped on Tuesday, with exporters pressured by a firmer yen against the dollar, while investors awaited clarity on the progress of negotiations to end the trade war between the United States and China. The benchmark Nikkei share average slid 0.5% to 23,292.65 and the broader Topix fell 0.2% […]

Read more
Taronis Announces Third Quarter Earning Call

Shareholder Call Scheduled for November 20th PHOENIX, AZ, Nov. 19, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading clean technology company in the renewable resources and environmental conservation industry, today announced it will hold a shareholder town hall meeting via teleconference on Wednesday, November 20th at 9:00am EST. […]

Read more
Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million

(Reuters) – An Oklahoma judge on Friday said Johnson & Johnson must pay that state $465 million for fueling the opioid epidemic through the deceptive marketing of painkillers, down from his original award of $572 million. FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary […]

Read more
China’s BeiGene gets FDA approval for drug to treat rare form of lymphoma

(Reuters) – The U.S. Food and Drug Administration on Thursday approved BeiGene Ltd’s lymphoma treatment, validating the China-based drugmaker’s strategy of largely using data from trials held outside the United States to file for approval. The company tested the treatment, Brukinsa, in 118 patients with mantle cell lymphoma enrolled in two studies. About three-quarters were […]

Read more
Taronis Launches Turkish Joint Venture

JV Formed to Support Expanded Turkish Business Model PHOENIX, AZ , Nov. 14, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading renewable fuel producer serving the global industrial gas markets, today announced the formation of a new joint venture within the Republic of Turkey. The new Turkish company is […]

Read more
J&J blockbuster loses ground to biosimilars despite Quebec court ruling

TORONTO/MONTREAL (Reuters) – Johnson & Johnson’s (JNJ.N) Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows. FILE PHOTO: The company logo for […]

Read more
Taronis Technologies Compliant with Nasdaq Listing Criteria

PHOENIX, AZ, Nov. 12, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading renewable fuel producer serving the global industrial gas markets, today announced that it has evidenced full compliance with all criteria for continued listing on Nasdaq. By letter dated November 8, 2019, Nasdaq informed the Company that it […]

Read more
AstraZeneca succeeds in treating lupus in late-stage study

The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid (Reuters) – AstraZeneca Plc said on Monday its experimental treatment significantly reduced disease activity in patients with autoimmune disorder lupus, in a late-stage study. […]

Read more
Klobuchar claims Warren’s health care plan would kick 149 million Americans off of their current insurance

If 2020 presidential hopeful Sen. Elizabeth Warren‘s, D-Mass., health care plan comes to fruition, it will bounce 149 million Americans off their current insurance plans, said challenger Sen. Amy Klobuchar, D-Minn., on “State of the Union” Sunday. “[Warren’s] pushing for a policy that I don’t agree with and would kick 149 million Americans off of their […]

Read more
U.S. company directors compensated more than ever, but now risk backlash

BOSTON (Reuters) – It’s nice work if you can get it. FILE PHOTO: Microsoft founder Bill Gates smiles while playing bridge with Warren Buffett, CEO of Berkshire Hathaway Inc, as part of the company annual meeting weekend in Omaha, Nebraska U.S. May 6, 2018. REUTERS/Rick Wilking/File Photo The average annual compensation for non-executive directors at […]

Read more